4.7 Review

Acute Coronary Syndrome in the COVID-19 Era-Differences and Dilemmas Compared to the Pre-COVID-19 Era

Related references

Note: Only part of the references are listed.
Review Nutrition & Dietetics

Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19

Muhammad Torequl Islam et al.

Summary: This study reviewed the latest publications on the modulatory effects of dietary supplements, vitamins, and minerals on the immune system in relation to COVID-19. The findings suggest that several dietary supplements have anti-viral effects and can be used as adjuvant therapy in the management of COVID-19.

INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2022)

Article Cardiac & Cardiovascular Systems

Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries

M. Linschoten et al.

Summary: Patients with heart disease have a higher mortality rate when hospitalized with COVID-19, but there is considerable heterogeneity in the association between different heart disease subtypes and in-hospital mortality. Patients with heart failure are at greatest risk of death during hospitalization with COVID-19.

EUROPEAN HEART JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis The Task Force for the management of COVID-19 of the European Society of Cardiology

Colin Baigent et al.

Summary: This two-part series aims to provide practical knowledge and guidance for clinicians in diagnosing and managing cardiovascular disease in association with COVID-19. The first part focuses on the epidemiology, pathophysiology, and diagnosis of cardiovascular conditions in COVID-19 patients, while the second part will address care pathways, treatment, and follow-up. Recommendations are based on current knowledge and observations, subject to change with increasing evidence and updates in the pandemic, and should not override local and national healthcare authorities' recommendations.

EUROPEAN HEART JOURNAL (2022)

Review Cardiac & Cardiovascular Systems

Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis

Francesco Sofi et al.

Summary: During the COVID-19 pandemic, hospitalizations for ST-segment elevation myocardial infarction decreased overall, with significant variability among countries, unrelated to COVID-related epidemiology or public health strategies. Instead, the discrepancies were inversely related to hospital bed availability in each country, highlighting the importance of healthcare organization during pandemics.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

Article Medicine, General & Internal

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Peter W. Horby et al.

Summary: In patients hospitalized with COVID-19, aspirin was not associated with reductions in 28-day mortality or in the risk of progressing to invasive mechanical ventilation or death, but was associated with a small increase in the rate of being discharged alive within 28 days.

LANCET (2022)

Review Virology

Coronary Stent Thrombosis in COVID-19 Patients: A Systematic Review of Cases Reported Worldwide

Wojciech Jan Skorupski et al.

Summary: Approximately 5 million percutaneous coronary interventions are performed worldwide annually. Stent-related complications, particularly stent thrombosis, are a serious concern. COVID-19 increases the risk of stent thrombosis, but comprehensive studies in this population are lacking.

VIRUSES-BASEL (2022)

Article Hematology

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis

Adam Cuker et al.

Summary: These guidelines aim to support the use of anticoagulation for thromboprophylaxis in COVID-19 patients without confirmed or suspected VTE. One conditional recommendation is against the use of outpatient anticoagulant prophylaxis in discharged COVID-19 patients.

BLOOD ADVANCES (2022)

Article Emergency Medicine

ST-elevation in an adolescent with COVID-19: Myopericarditis or myocardial infarction?

Cathie-Kim Le et al.

Summary: COVID-19 can lead to myocardial infarctions and myopericarditis as cardiac complications, although myocardial infarctions are rare in children. Differentiation between myocardial infarctions and myopericarditis can be made through ECG and echocardiogram. Therefore, awareness of MIS-C and its cardiac complications is crucial for children with COVID-19.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2022)

Review Pharmacology & Pharmacy

Potential Dexamethasone-Direct Oral Anticoagulant Drug Interaction: Is This a Concern in COVID?

Maureen A. Smythe et al.

Summary: The potential interaction between dexamethasone and DOACs through CYP3A4 and/or P-gp induction, especially in hospitalized COVID-19 patients with evidence of COVID coagulopathy, may affect anticoagulant efficacy during heightened thrombotic risk.

ANNALS OF PHARMACOTHERAPY (2022)

Article Cardiac & Cardiovascular Systems

Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone

Nicola Potere et al.

Summary: This study found that dexamethasone administration or acute COVID-19 did not appear to affect DOAC levels in hospitalized, non-critically ill COVID-19 patients.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)

Article Medicine, General & Internal

Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection

Ricardo Rubini-Costa et al.

Summary: This study investigated the management of anticoagulation therapy in atrial fibrillation (AF) patients admitted with severe COVID-19. The results showed that low-molecular-weight heparin was the main anticoagulant used, and AF patients had a higher incidence of major bleeding and mortality compared to non-AF patients. The presence of AF and high levels of D-dimer were identified as independent predictors of in-hospital major bleeding. Therefore, individualized anticoagulation therapy considering specific bleeding and thrombotic risk is recommended for AF patients admitted with COVID-19.

MEDICINA CLINICA (2022)

Article Geriatrics & Gerontology

Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study

M. T. H. M. Henkens et al.

Summary: Age is the main determinant of COVID-19 related in-hospital mortality, with negligible mediation effect of pre-existing comorbidities.

BMC GERIATRICS (2022)

Article Microbiology

Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro

Maria I. Zapata-Cardona et al.

Summary: This article evaluates the in vitro antiviral effect of atorvastatin (ATV) against SARS-CoV-2 and identifies its interaction affinity with two SARS-CoV-2 proteins. The results show that ATV demonstrates antiviral activity against different treatment strategies and variants, with a favorable binding affinity with viral proteins. Considering the extensive clinical experience of ATV use, it could be valuable in the treatment of COVID-19.

FRONTIERS IN MICROBIOLOGY (2022)

Article Health Care Sciences & Services

Impact of COVID-19 Pandemic on Hospital Admissions of Acute Coronary Syndrome: A Beijing Inpatient Database Study

Liu He et al.

Summary: During the COVID-19 pandemic in Beijing, there was a significant reduction in admissions for acute coronary syndrome (ACS), but no significant increase in admissions for heart failure (HF) was observed. This suggests that the pandemic did not worsen the short-term prognosis for ACS.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2022)

Review Pharmacology & Pharmacy

Analytical Challenges and Metrological Approaches to Ensuring Dietary Supplement Quality: International Perspectives

Alessandra Durazzo et al.

Summary: This article discusses the utility of applying rigorous analytical techniques and adopting metrological principles in studying dietary supplement products and ingredients. It provides an assessment of current and emerging dietary supplement characterization methods, highlighting the importance of quality assessment, statistical methods, and data management. It also describes a new frontier for metrology in dietary supplement science and the need for collaboration between different scientists.

FRONTIERS IN PHARMACOLOGY (2022)

Article Emergency Medicine

Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis

Anwar Santoso et al.

Summary: This study found that cardiac injury in patients with COVID-19 pneumonia is associated with higher mortality, need for ICU care, and severity of the disease. However, cardiac injury does not significantly increase the risk of ARDS.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Letter Cardiac & Cardiovascular Systems

Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient

Martin Hinterseer et al.

CLINICAL RESEARCH IN CARDIOLOGY (2021)

Review Cardiac & Cardiovascular Systems

A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs

Wen-Liang Yu et al.

Summary: COVID-19 affects the cardiovascular system through direct damage from the virus and subsequent cytokine storm, while potential anti-COVID-19 drugs, including antiviral regimens and immunomodulatory regimens, may also have risks to the cardiovascular system, especially in altering cardiac conduction.

CARDIOVASCULAR DRUGS AND THERAPY (2021)

Article Cardiac & Cardiovascular Systems

Impact ofCOVID-19 pandemic onSTEMIcare: An expanded analysis from the United States

Santiago Garcia et al.

Summary: The COVID-19 pandemic mitigation measures have led to a significant decrease in activations for STEMI care, angiography, and PPCI. Additionally, there has been an increase in average D2B times, indicating a negative impact on timely access to cardiac catheterization laboratories for PPCI.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2021)

Review Peripheral Vascular Disease

Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19

Amir Abbas Momtazi-Borojeni et al.

Summary: This review examines the role of coronavirus spike protein and ACE2 receptor in infection, and discusses the therapeutic effect of inhibiting ACE2, providing insights for finding effective treatment targets in research.

ANGIOLOGY (2021)

Article Immunology

Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States

Michael W. Fried et al.

Summary: This study analyzed a large cohort of COVID-19 patients hospitalized in the United States, identifying factors such as male sex, older age, obesity, geographic region, chronic kidney disease, and preexisting cardiovascular disease associated with increased odds of mechanical ventilation and death. These data can guide strategies for prioritizing prevention and treatment of the disease.

CLINICAL INFECTIOUS DISEASES (2021)

Article Cardiac & Cardiovascular Systems

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Jean-Philippe Collet et al.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19

Paraskevi Theocharis et al.

Summary: This study utilized multimodality imaging to describe the cardiac involvement in a new multisystem inflammatory condition following the peak of the UK COVID-19 epidemic in young people. The findings revealed common pancarditis with cardiac dysfunction, myocardial oedema, and coronary artery dilatation, highlighting the need for close monitoring due to the risk of thrombotic myocardial infarction.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2021)

Review Virology

The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis

Yixuan Wang et al.

Summary: Analysis of hypertensive COVID-19 patients treated with ACEI/ARB showed a lower risk of mortality and ventilatory support, with no significant impact of factors such as age, gender, study site, and comorbidities on the effectiveness of ACEI/ARB treatment.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Cardiac & Cardiovascular Systems

2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Martha Gulati et al.

Summary: The clinical practice guideline provides recommendations and algorithms for clinicians to assess and diagnose chest pain in adult patients based on contemporary evidence, emphasizing risk stratification and diagnostic workup, and recommending shared decision-making with patients.

CIRCULATION (2021)

Article Medicine, General & Internal

Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England

Muhammad Rashid et al.

Summary: This study identified that 4% of hospitalized ACS patients in England had concurrent COVID-19 infection, and these patients presented with poorer clinical characteristics upon admission and had higher mortality rates.

JOURNAL OF INTERNAL MEDICINE (2021)

Article Medicine, General & Internal

Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction

Marwan Saad et al.

Summary: Limited research was conducted on patients with ST-segment elevation myocardial infarction (STEMI) and COVID-19. This study compared characteristics, treatment, and outcomes of patients with STEMI with vs without COVID-19 infection. The results showed that having a concomitant diagnosis of COVID-19 was significantly associated with higher rates of in-hospital mortality among patients with out-of-hospital or in-hospital STEMI compared with patients without a diagnosis of COVID-19 from the past year.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Cardiac & Cardiovascular Systems

Case Report: Emergency CABG Following Failure of PTCA in a COVID-19 Patient

Silvia Romiti et al.

Summary: The impact of COVID-19 on patients undergoing cardiac surgery using CPB is still uncertain, as it may lead to severe complications. International guidelines currently lack standard management protocols for these patients.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Emergency Medicine

Electrocardiographic manifestations of COVID-19

Brit Long et al.

Summary: COVID-19 is associated with a variety of ECG abnormalities, with sinus tachycardia being the most common, along with atrial fibrillation, QT interval prolongation, and others. These ECG presentations may have implications for patient outcomes.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Review Medicine, General & Internal

Impact of cardiovascular diseases on severity of COVID-19 patients: A systematic review

Pinki Mishra et al.

Summary: Cardiovascular disease is significantly associated with severity and mortality in COVID-19 patients, as well as other comorbidities such as diabetes, hypertension, and chronic kidney disease. Further prevalence studies are needed to understand the full extent of these risk factors.

ANNALS ACADEMY OF MEDICINE SINGAPORE (2021)

Editorial Material Cardiac & Cardiovascular Systems

Inflammatory syndrome in children associated with COVID-19 complicated by acute myocardial infarction

Elena Reffo et al.

EUROPEAN HEART JOURNAL (2021)

Article Multidisciplinary Sciences

Myocardial injury in hospitalized patients with COVID-19 infection-Risk factors and outcomes

Orly Efros et al.

Summary: This study identified age, female sex, low systolic blood pressure, and increased creatinine level as risk factors for myocardial injury in hospitalized patients with COVID-19. Elevated troponin levels were associated with a significantly higher risk of death and invasive ventilation support in these patients, indicating poor prognosis.

PLOS ONE (2021)

Article Cardiac & Cardiovascular Systems

Atrial fibrillation in patients with COVID-19. Usefulness of the CHA(2)DS(2)-VASc score: an analysis of the international HOPE COVID-19 registry

Aitor Uribarri et al.

Summary: Atrial fibrillation (AF) in COVID-19 patients is associated with a higher number of complications and a higher 60-day mortality rate. The CHA(2)DS(2)-VASc score may be a good risk marker in COVID patients but does not predict their embolic risk.

REVISTA ESPANOLA DE CARDIOLOGIA (2021)

Review Biotechnology & Applied Microbiology

Improved COVID-19 Outcomes following Statin Therapy: An Updated Systematic Review and Meta-analysis

Amir Vahedian-Azimi et al.

Summary: This meta-analysis found that treatment with statins did not significantly affect ICU admission and all-cause mortality but did reduce tracheal intubation in COVID-19 cases. The analysis showed a significant reduction in death outcomes for patients who received statins during hospitalization, with no significant effect of statin therapy before hospital admission.

BIOMED RESEARCH INTERNATIONAL (2021)

Article Peripheral Vascular Disease

COVID and Cardiovascular Disease: What We Know in 2021

Michael Chilazi et al.

Current Atherosclerosis Reports (2021)

Review Biochemistry & Molecular Biology

COVID-19: Direct and Indirect Mechanisms of Statins

Agnieszka Pawlos et al.

Summary: The virus responsible for COVID-19 is SARS-CoV-2, which can progress to ARDS; statin therapy may decrease mortality in COVID-19 patients through various mechanisms, but potential side effects should be considered.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cardiac & Cardiovascular Systems

COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy

Radu Tanacli et al.

Summary: Despite the ongoing global pandemic, the impact of COVID-19 on cardiac structure and function is still not completely understood. Myocarditis is a rare but potentially serious complication of other viral infections with variable recovery, and is, in some cases, associated with long-term cardiac remodeling and functional impairment. The study revealed that SARS-CoV-2 infection was associated with relatively mild but variable cardiac involvement, with more symptomatic COVID-19 patients and those with higher clinical care demands more likely to exhibit chronic inflammation and impaired cardiac function compared to patients with milder forms of the disease.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients

Oriol Rodriguez-Leor et al.

Summary: This study aimed to assess clinical and prognosis differences in patients with COVID-19 and STEMI. Clinical characteristics were similar between the groups, but COVID-19 patients had more heart failure on arrival. COVID-19 patients had higher in-hospital mortality, stent thrombosis, and cardiogenic shock development after PCI compared to non-COVID-19 STEMI patients.

EUROINTERVENTION (2021)

Review Cardiac & Cardiovascular Systems

Pharmacotherapy of atrial fibrillation in COVID-19 patients

Anna Tomaszuk-Kazberuk et al.

Summary: The pharmacotherapy for atrial fibrillation (AF) patients in the context of the COVID-19 pandemic should be individualized based on the severity of the illness, with a preference for non-vitamin K antagonist oral anticoagulants (NOACs) in less severe cases and low-molecular-weight heparin (LMWH) or unfractionated heparin in more severe cases.

CARDIOLOGY JOURNAL (2021)

Article Hematology

Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis

Pablo Demelo-Rodriguez et al.

Summary: Among patients hospitalized with COVID-19 receiving intermediate- or therapeutic-intensity anticoagulation, a major bleeding event occurred in 5.7%. Use of therapeutic-intensity anticoagulation, critical illness, and elevated D-dimer or ferritin levels at admission were associated with increased risk for major bleeding.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Medicine, General & Internal

Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study

Ioannis Katsoularis et al.

Summary: This study in Sweden quantified the risk of acute myocardial infarction and ischaemic stroke associated with COVID-19, finding a significant correlation.

LANCET (2021)

Article Medicine, General & Internal

SARS-CoV-2 infection: A predisposing factor for acute coronary syndrome

Cristina de Cortina Camarero et al.

Summary: The incidence of ACS is higher in COVID-19 patients, often associated with severe infection and poor prognosis. This suggests the need for careful monitoring and management in this patient population.

MEDICINA CLINICA (2021)

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

Patrick R. Lawler et al.

Summary: This study showed that therapeutic-dose anticoagulation with heparin in non-critically ill patients with Covid-19 increased the likelihood of survival to hospital discharge and reduced the need for cardiovascular or respiratory organ support compared to usual-care thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Pediatrics

ST-Elevation Myocardial Infarction due to Acute Thrombosis in an Adolescent With COVID-19

Jessica Persson et al.

Summary: This case report presents a 15-year-old girl with coronary thrombosis-induced ST-elevation myocardial infarction associated with COVID-19. It is noteworthy that while ST-elevation MI has been identified as a presentation of COVID-19 in adults, it has not been reported in children. This highlights the importance of considering MI in children with myocardial dysfunction associated with COVID-19.

PEDIATRICS (2021)

Article Multidisciplinary Sciences

Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes-A multicenter registry

Alexander Fardman et al.

Summary: During the Covid-19 outbreak in 2020, STEMI patients had more severe disease status and a higher rate of in-hospital adverse events upon admission compared to the parallel period in 2018. The total ischemic time was longer for STEMI patients admitted during the Covid-19 era.

PLOS ONE (2021)

Article Biochemistry & Molecular Biology

Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks

Louisa Ruhl et al.

Summary: The study investigated the immune response in severe COVID-19 patients during acute phase and in convalescent patients, revealing a highly inflammatory microenvironment and endothelial injury in severe cases.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Immunology

Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

Aldo Bonaventura et al.

Summary: The authors suggest that SARS-CoV-2 infection induces a prothrombotic state and dysregulated immunothrombosis, leading to severe manifestations of COVID-19. They also discuss potential antithrombotic and immunomodulating drugs for treating COVID-19 patients, aiming to reduce the acute and long-term consequences of the disease by targeting immunothrombosis.

NATURE REVIEWS IMMUNOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

CT pulmonary angiography in COVID-19 pneumonia: relationship between pulmonary embolism and disease severity

Aya Yassin et al.

Summary: This study aimed to evaluate the incidence of PE in patients with COVID-19 infection, with 41.7% of patients showing positive PE. While no significant correlation was found between PE incidence and age, sex, laboratory results, and CT severity of COVID-19, a significant relationship was found with symptoms such as desaturation, hemoptysis, and chest pain, as well as rising D-dimer levels and progressive CT findings.

EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE (2021)

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Cardiac & Cardiovascular Systems

ST-Elevation Myocardial Infarction in Patients With COVID-19 Clinical and Angiographic Outcomes

Giulio G. Stefanini et al.

CIRCULATION (2020)

Article Cardiac & Cardiovascular Systems

COVID-19 and Cardiovascular Disease

Kevin J. Clerkin et al.

CIRCULATION (2020)

Article Chemistry, Medicinal

COVID-19 treatment by repurposing drugs until the vaccine is in sight

Mrudula Phadke et al.

DRUG DEVELOPMENT RESEARCH (2020)

Editorial Material Cardiac & Cardiovascular Systems

Spontaneous Coronary Artery Dissection in a Patient With COVID-19

Pierre-Yves Courand et al.

JACC-CARDIOVASCULAR INTERVENTIONS (2020)

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Letter Medicine, General & Internal

Endothelial cell infection and endotheliitis in COVID-19

Zsuzsanna Varga et al.

LANCET (2020)

Review Endocrinology & Metabolism

Impact of sex and gender on COVID-19 outcomes in Europe

Catherine Gebhard et al.

BIOLOGY OF SEX DIFFERENCES (2020)

Article Cardiac & Cardiovascular Systems

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Tao Guo et al.

JAMA CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

Shaobo Shi et al.

JAMA CARDIOLOGY (2020)

Letter Medicine, General & Internal

Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy

Ovidio De Filippo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Cardiac & Cardiovascular Systems

Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-ACS admissions

A. K. Gitt et al.

CLINICAL RESEARCH IN CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

COVID-19 and cardiac arrhythmias

Anjali Bhatla et al.

HEART RHYTHM (2020)

Article Medicine, General & Internal

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US

Shruti Gupta et al.

JAMA INTERNAL MEDICINE (2020)

Review Endocrinology & Metabolism

Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

Emma Barron et al.

LANCET DIABETES & ENDOCRINOLOGY (2020)

Article Cardiac & Cardiovascular Systems

COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies

Rakesh Gopinathannair et al.

JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection

Anuradha Lala et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction

Fizzah A. Choudry et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Medicine, General & Internal

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England

Marion M. Mafham et al.

LANCET (2020)

Letter Cardiac & Cardiovascular Systems

Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction

Daniel Modin et al.

CIRCULATION (2020)

Review Cardiac & Cardiovascular Systems

Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review

Chirag Bavishi et al.

PROGRESS IN CARDIOVASCULAR DISEASES (2020)

Article Cardiac & Cardiovascular Systems

Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction

Chun Shing Kwok et al.

HEART (2020)

Article Cardiac & Cardiovascular Systems

Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19

Bradley Peltzer et al.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China

Dingcheng Xiang et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

Girish N. Nadkarni et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Atherosclerotic spontaneous coronary artery dissection (A-SCAD) in a patient with COVID-19: case report and possible

Remo Albiero et al.

EUROPEAN HEART JOURNAL-CASE REPORTS (2020)

Article Cardiac & Cardiovascular Systems

Delays in Presentation in Patients With Acute Myocardial Infarction During the COVID-19 Pandemic

Ali Aldujeli et al.

CARDIOLOGY RESEARCH (2020)

Letter Hematology

Anticoagulation in COVID-19: DDI Perspective

Sajad Khiali et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2020)

Article Medicine, General & Internal

Type II Myocardial Infarction: Predisposing Factors, Precipitating Elements, and Outcomes

Bharat Pillai et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

Article Medicine, General & Internal

Statins and the COVID-19 main protease: in silico evidence on direct interaction

Zeljko Reiner et al.

ARCHIVES OF MEDICAL SCIENCE (2020)

Editorial Material Cardiac & Cardiovascular Systems

The Many Faces of Type 2 Myocardial Infarction

James L. Januzzi et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Acute myocardial infarction and influenza: a meta-analysis of case-control studies

Michelle Barnes et al.

HEART (2015)

Article Medicine, General & Internal

Atrial Fibrillation and the Risk of Myocardial Infarction

Elsayed Z. Soliman et al.

JAMA INTERNAL MEDICINE (2014)

Review Medicine, General & Internal

Acute Coronary Syndromes: Diagnosis and Management, Part I

Amit Kumar et al.

MAYO CLINIC PROCEEDINGS (2009)

Article Medicine, General & Internal

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

I Iakovou et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)